Amelioration of hepatic ischemia/reperfusion injury in the remnant liver after partial hepatectomy in rats

Background and Aims:  Reactive oxygen species have been implicated in the development of hepatic ischemia/reperfusion (I/R) injury. I/R injury remains an important problem in massive hepatectomy and organ transplantation. The aim of this study was to examine the effect of edaravone, a newly synthesi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of gastroenterology and hepatology 2007-12, Vol.22 (12), p.2167-2172
Hauptverfasser: Hiranuma, Susumu, Ito, Koji, Noda, Yumi, Ozasa, Hisashi, Koike, Yuichi, Horikawa, Saburo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2172
container_issue 12
container_start_page 2167
container_title Journal of gastroenterology and hepatology
container_volume 22
creator Hiranuma, Susumu
Ito, Koji
Noda, Yumi
Ozasa, Hisashi
Koike, Yuichi
Horikawa, Saburo
description Background and Aims:  Reactive oxygen species have been implicated in the development of hepatic ischemia/reperfusion (I/R) injury. I/R injury remains an important problem in massive hepatectomy and organ transplantation. The aim of this study was to examine the effect of edaravone, a newly synthesized free radical scavenger, on I/R injury in the remnant liver after partial hepatectomy in rats. Methods:  Partial (70%) hepatic ischemia was induced in rats by occluding the hepatic artery, portal vein, and bile duct to left and median lobes of liver. Total hepatic ischemia (Pringle maneuver) was induced by occluding the hepatoduodenal ligament. Edaravone was intravenously administered to rats just before reperfusion and partial (70%) hepatectomy was performed just after reperfusion. Results:  Edaravone significantly reduced the increases in the levels of serum alanine aminotransferase and aspartate aminotransferase in rats with liver injury induced by 90‐min of partial ischemia followed by 120‐min of reperfusion. Histopathological analysis showed that edaravone prevented inflammatory changes in the livers with I/R injury. Edaravone also decreased the levels of myeloperoxidase activity, which is an index of neutrophil infiltration, and interleukin‐6 mRNA, which is a proinflammatory cytokine. Additionally, edaravone improved the survival rate in partial hepatectomy rats with I/R injury induced by the Pringle maneuver. Conclusions:  Edaravone administration prior to reperfusion protected the liver against I/R injury. Edaravone also improved the function of the remnant liver with I/R injury after partial hepatectomy. Therefore, edaravone may have applicability for major hepatectomy and liver transplantation in the clinical setting.
doi_str_mv 10.1111/j.1440-1746.2006.04779.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68544363</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68544363</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5019-d97181b8b8100463cca019484de46e9fe753480f5c83a7023b7d50a35389cdf43</originalsourceid><addsrcrecordid>eNqNkE1v3CAQhlHVKtmm-QuVL-3NDixg4NBDFDWbRqv20FQ5IhYPWlx_Fexm998Xx6vkWg7MiHnemeFFKCO4IOlc1QVhDOdEsLJYY1wWmAmhisMbtHopvEUrLAnPFSXqHL2PscYYMyz4GTonElNCRblC9XULje-DGX3fZb3L9jCk3GY-2j203lwFGCC4Kc5139VTOKaQjXvIArSd6cas8X8hZMaN6R5MGL1pljZgx759xlP_-AG9c6aJcHmKF-jX7deHm7t8-2Pz7eZ6m1uOicorJYgkO7mTJO1bUmtNemaSVcBKUA4Ep0xix62kRuA13YmKY0M5lcpWjtEL9HnpO4T-zwRx1G36DDSN6aCfoi4lZ4yWNIFyAW3oYwzg9BB8a8JRE6xnn3WtZzv1bKeefdbPPutDkn48zZh2LVSvwpOxCfh0Aky0pnHBdNbHV04psi7JvMOXhXvyDRz_ewF9v7mbs6TPF72PIxxe9Cb81qWgguvH7xt9T38-PGIu9Zb-AwoxqMY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68544363</pqid></control><display><type>article</type><title>Amelioration of hepatic ischemia/reperfusion injury in the remnant liver after partial hepatectomy in rats</title><source>Wiley-Blackwell Journals</source><source>MEDLINE</source><creator>Hiranuma, Susumu ; Ito, Koji ; Noda, Yumi ; Ozasa, Hisashi ; Koike, Yuichi ; Horikawa, Saburo</creator><creatorcontrib>Hiranuma, Susumu ; Ito, Koji ; Noda, Yumi ; Ozasa, Hisashi ; Koike, Yuichi ; Horikawa, Saburo</creatorcontrib><description>Background and Aims:  Reactive oxygen species have been implicated in the development of hepatic ischemia/reperfusion (I/R) injury. I/R injury remains an important problem in massive hepatectomy and organ transplantation. The aim of this study was to examine the effect of edaravone, a newly synthesized free radical scavenger, on I/R injury in the remnant liver after partial hepatectomy in rats. Methods:  Partial (70%) hepatic ischemia was induced in rats by occluding the hepatic artery, portal vein, and bile duct to left and median lobes of liver. Total hepatic ischemia (Pringle maneuver) was induced by occluding the hepatoduodenal ligament. Edaravone was intravenously administered to rats just before reperfusion and partial (70%) hepatectomy was performed just after reperfusion. Results:  Edaravone significantly reduced the increases in the levels of serum alanine aminotransferase and aspartate aminotransferase in rats with liver injury induced by 90‐min of partial ischemia followed by 120‐min of reperfusion. Histopathological analysis showed that edaravone prevented inflammatory changes in the livers with I/R injury. Edaravone also decreased the levels of myeloperoxidase activity, which is an index of neutrophil infiltration, and interleukin‐6 mRNA, which is a proinflammatory cytokine. Additionally, edaravone improved the survival rate in partial hepatectomy rats with I/R injury induced by the Pringle maneuver. Conclusions:  Edaravone administration prior to reperfusion protected the liver against I/R injury. Edaravone also improved the function of the remnant liver with I/R injury after partial hepatectomy. Therefore, edaravone may have applicability for major hepatectomy and liver transplantation in the clinical setting.</description><identifier>ISSN: 0815-9319</identifier><identifier>EISSN: 1440-1746</identifier><identifier>DOI: 10.1111/j.1440-1746.2006.04779.x</identifier><identifier>PMID: 18031376</identifier><language>eng</language><publisher>Melbourne, Australia: Blackwell Publishing Asia</publisher><subject>Animals ; Antipyrine - analogs &amp; derivatives ; Antipyrine - pharmacology ; Biological and medical sciences ; Cardiology. Vascular system ; Free Radical Scavengers - pharmacology ; Gastroenterology. Liver. Pancreas. Abdomen ; Gene Expression Regulation - drug effects ; Hepatectomy - methods ; Interleukin-6 - genetics ; Interleukin-6 - metabolism ; ischemia/reperfusion ; liver ; Liver - drug effects ; Liver - enzymology ; Liver - metabolism ; Liver - pathology ; Liver Diseases - enzymology ; Liver Diseases - mortality ; Liver Diseases - pathology ; Liver, biliary tract, pancreas, portal circulation, spleen ; Liver. Biliary tract. Portal circulation. Exocrine pancreas ; Male ; Medical sciences ; neutrophil ; Other diseases. Semiology ; partial hepatectomy ; Peroxidase - metabolism ; Rats ; Rats, Wistar ; Reperfusion Injury - prevention &amp; control ; RNA, Messenger - genetics ; RNA, Messenger - metabolism ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the digestive system ; Survival Rate ; transplantation</subject><ispartof>Journal of gastroenterology and hepatology, 2007-12, Vol.22 (12), p.2167-2172</ispartof><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5019-d97181b8b8100463cca019484de46e9fe753480f5c83a7023b7d50a35389cdf43</citedby><cites>FETCH-LOGICAL-c5019-d97181b8b8100463cca019484de46e9fe753480f5c83a7023b7d50a35389cdf43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1440-1746.2006.04779.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1440-1746.2006.04779.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19912613$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18031376$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hiranuma, Susumu</creatorcontrib><creatorcontrib>Ito, Koji</creatorcontrib><creatorcontrib>Noda, Yumi</creatorcontrib><creatorcontrib>Ozasa, Hisashi</creatorcontrib><creatorcontrib>Koike, Yuichi</creatorcontrib><creatorcontrib>Horikawa, Saburo</creatorcontrib><title>Amelioration of hepatic ischemia/reperfusion injury in the remnant liver after partial hepatectomy in rats</title><title>Journal of gastroenterology and hepatology</title><addtitle>J Gastroenterol Hepatol</addtitle><description>Background and Aims:  Reactive oxygen species have been implicated in the development of hepatic ischemia/reperfusion (I/R) injury. I/R injury remains an important problem in massive hepatectomy and organ transplantation. The aim of this study was to examine the effect of edaravone, a newly synthesized free radical scavenger, on I/R injury in the remnant liver after partial hepatectomy in rats. Methods:  Partial (70%) hepatic ischemia was induced in rats by occluding the hepatic artery, portal vein, and bile duct to left and median lobes of liver. Total hepatic ischemia (Pringle maneuver) was induced by occluding the hepatoduodenal ligament. Edaravone was intravenously administered to rats just before reperfusion and partial (70%) hepatectomy was performed just after reperfusion. Results:  Edaravone significantly reduced the increases in the levels of serum alanine aminotransferase and aspartate aminotransferase in rats with liver injury induced by 90‐min of partial ischemia followed by 120‐min of reperfusion. Histopathological analysis showed that edaravone prevented inflammatory changes in the livers with I/R injury. Edaravone also decreased the levels of myeloperoxidase activity, which is an index of neutrophil infiltration, and interleukin‐6 mRNA, which is a proinflammatory cytokine. Additionally, edaravone improved the survival rate in partial hepatectomy rats with I/R injury induced by the Pringle maneuver. Conclusions:  Edaravone administration prior to reperfusion protected the liver against I/R injury. Edaravone also improved the function of the remnant liver with I/R injury after partial hepatectomy. Therefore, edaravone may have applicability for major hepatectomy and liver transplantation in the clinical setting.</description><subject>Animals</subject><subject>Antipyrine - analogs &amp; derivatives</subject><subject>Antipyrine - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Cardiology. Vascular system</subject><subject>Free Radical Scavengers - pharmacology</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Hepatectomy - methods</subject><subject>Interleukin-6 - genetics</subject><subject>Interleukin-6 - metabolism</subject><subject>ischemia/reperfusion</subject><subject>liver</subject><subject>Liver - drug effects</subject><subject>Liver - enzymology</subject><subject>Liver - metabolism</subject><subject>Liver - pathology</subject><subject>Liver Diseases - enzymology</subject><subject>Liver Diseases - mortality</subject><subject>Liver Diseases - pathology</subject><subject>Liver, biliary tract, pancreas, portal circulation, spleen</subject><subject>Liver. Biliary tract. Portal circulation. Exocrine pancreas</subject><subject>Male</subject><subject>Medical sciences</subject><subject>neutrophil</subject><subject>Other diseases. Semiology</subject><subject>partial hepatectomy</subject><subject>Peroxidase - metabolism</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Reperfusion Injury - prevention &amp; control</subject><subject>RNA, Messenger - genetics</subject><subject>RNA, Messenger - metabolism</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the digestive system</subject><subject>Survival Rate</subject><subject>transplantation</subject><issn>0815-9319</issn><issn>1440-1746</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkE1v3CAQhlHVKtmm-QuVL-3NDixg4NBDFDWbRqv20FQ5IhYPWlx_Fexm998Xx6vkWg7MiHnemeFFKCO4IOlc1QVhDOdEsLJYY1wWmAmhisMbtHopvEUrLAnPFSXqHL2PscYYMyz4GTonElNCRblC9XULje-DGX3fZb3L9jCk3GY-2j203lwFGCC4Kc5139VTOKaQjXvIArSd6cas8X8hZMaN6R5MGL1pljZgx759xlP_-AG9c6aJcHmKF-jX7deHm7t8-2Pz7eZ6m1uOicorJYgkO7mTJO1bUmtNemaSVcBKUA4Ep0xix62kRuA13YmKY0M5lcpWjtEL9HnpO4T-zwRx1G36DDSN6aCfoi4lZ4yWNIFyAW3oYwzg9BB8a8JRE6xnn3WtZzv1bKeefdbPPutDkn48zZh2LVSvwpOxCfh0Aky0pnHBdNbHV04psi7JvMOXhXvyDRz_ewF9v7mbs6TPF72PIxxe9Cb81qWgguvH7xt9T38-PGIu9Zb-AwoxqMY</recordid><startdate>200712</startdate><enddate>200712</enddate><creator>Hiranuma, Susumu</creator><creator>Ito, Koji</creator><creator>Noda, Yumi</creator><creator>Ozasa, Hisashi</creator><creator>Koike, Yuichi</creator><creator>Horikawa, Saburo</creator><general>Blackwell Publishing Asia</general><general>Blackwell Science</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200712</creationdate><title>Amelioration of hepatic ischemia/reperfusion injury in the remnant liver after partial hepatectomy in rats</title><author>Hiranuma, Susumu ; Ito, Koji ; Noda, Yumi ; Ozasa, Hisashi ; Koike, Yuichi ; Horikawa, Saburo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5019-d97181b8b8100463cca019484de46e9fe753480f5c83a7023b7d50a35389cdf43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Animals</topic><topic>Antipyrine - analogs &amp; derivatives</topic><topic>Antipyrine - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Cardiology. Vascular system</topic><topic>Free Radical Scavengers - pharmacology</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Hepatectomy - methods</topic><topic>Interleukin-6 - genetics</topic><topic>Interleukin-6 - metabolism</topic><topic>ischemia/reperfusion</topic><topic>liver</topic><topic>Liver - drug effects</topic><topic>Liver - enzymology</topic><topic>Liver - metabolism</topic><topic>Liver - pathology</topic><topic>Liver Diseases - enzymology</topic><topic>Liver Diseases - mortality</topic><topic>Liver Diseases - pathology</topic><topic>Liver, biliary tract, pancreas, portal circulation, spleen</topic><topic>Liver. Biliary tract. Portal circulation. Exocrine pancreas</topic><topic>Male</topic><topic>Medical sciences</topic><topic>neutrophil</topic><topic>Other diseases. Semiology</topic><topic>partial hepatectomy</topic><topic>Peroxidase - metabolism</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Reperfusion Injury - prevention &amp; control</topic><topic>RNA, Messenger - genetics</topic><topic>RNA, Messenger - metabolism</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the digestive system</topic><topic>Survival Rate</topic><topic>transplantation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hiranuma, Susumu</creatorcontrib><creatorcontrib>Ito, Koji</creatorcontrib><creatorcontrib>Noda, Yumi</creatorcontrib><creatorcontrib>Ozasa, Hisashi</creatorcontrib><creatorcontrib>Koike, Yuichi</creatorcontrib><creatorcontrib>Horikawa, Saburo</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of gastroenterology and hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hiranuma, Susumu</au><au>Ito, Koji</au><au>Noda, Yumi</au><au>Ozasa, Hisashi</au><au>Koike, Yuichi</au><au>Horikawa, Saburo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Amelioration of hepatic ischemia/reperfusion injury in the remnant liver after partial hepatectomy in rats</atitle><jtitle>Journal of gastroenterology and hepatology</jtitle><addtitle>J Gastroenterol Hepatol</addtitle><date>2007-12</date><risdate>2007</risdate><volume>22</volume><issue>12</issue><spage>2167</spage><epage>2172</epage><pages>2167-2172</pages><issn>0815-9319</issn><eissn>1440-1746</eissn><abstract>Background and Aims:  Reactive oxygen species have been implicated in the development of hepatic ischemia/reperfusion (I/R) injury. I/R injury remains an important problem in massive hepatectomy and organ transplantation. The aim of this study was to examine the effect of edaravone, a newly synthesized free radical scavenger, on I/R injury in the remnant liver after partial hepatectomy in rats. Methods:  Partial (70%) hepatic ischemia was induced in rats by occluding the hepatic artery, portal vein, and bile duct to left and median lobes of liver. Total hepatic ischemia (Pringle maneuver) was induced by occluding the hepatoduodenal ligament. Edaravone was intravenously administered to rats just before reperfusion and partial (70%) hepatectomy was performed just after reperfusion. Results:  Edaravone significantly reduced the increases in the levels of serum alanine aminotransferase and aspartate aminotransferase in rats with liver injury induced by 90‐min of partial ischemia followed by 120‐min of reperfusion. Histopathological analysis showed that edaravone prevented inflammatory changes in the livers with I/R injury. Edaravone also decreased the levels of myeloperoxidase activity, which is an index of neutrophil infiltration, and interleukin‐6 mRNA, which is a proinflammatory cytokine. Additionally, edaravone improved the survival rate in partial hepatectomy rats with I/R injury induced by the Pringle maneuver. Conclusions:  Edaravone administration prior to reperfusion protected the liver against I/R injury. Edaravone also improved the function of the remnant liver with I/R injury after partial hepatectomy. Therefore, edaravone may have applicability for major hepatectomy and liver transplantation in the clinical setting.</abstract><cop>Melbourne, Australia</cop><pub>Blackwell Publishing Asia</pub><pmid>18031376</pmid><doi>10.1111/j.1440-1746.2006.04779.x</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0815-9319
ispartof Journal of gastroenterology and hepatology, 2007-12, Vol.22 (12), p.2167-2172
issn 0815-9319
1440-1746
language eng
recordid cdi_proquest_miscellaneous_68544363
source Wiley-Blackwell Journals; MEDLINE
subjects Animals
Antipyrine - analogs & derivatives
Antipyrine - pharmacology
Biological and medical sciences
Cardiology. Vascular system
Free Radical Scavengers - pharmacology
Gastroenterology. Liver. Pancreas. Abdomen
Gene Expression Regulation - drug effects
Hepatectomy - methods
Interleukin-6 - genetics
Interleukin-6 - metabolism
ischemia/reperfusion
liver
Liver - drug effects
Liver - enzymology
Liver - metabolism
Liver - pathology
Liver Diseases - enzymology
Liver Diseases - mortality
Liver Diseases - pathology
Liver, biliary tract, pancreas, portal circulation, spleen
Liver. Biliary tract. Portal circulation. Exocrine pancreas
Male
Medical sciences
neutrophil
Other diseases. Semiology
partial hepatectomy
Peroxidase - metabolism
Rats
Rats, Wistar
Reperfusion Injury - prevention & control
RNA, Messenger - genetics
RNA, Messenger - metabolism
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the digestive system
Survival Rate
transplantation
title Amelioration of hepatic ischemia/reperfusion injury in the remnant liver after partial hepatectomy in rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T17%3A38%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Amelioration%20of%20hepatic%20ischemia/reperfusion%20injury%20in%20the%20remnant%20liver%20after%20partial%20hepatectomy%20in%20rats&rft.jtitle=Journal%20of%20gastroenterology%20and%20hepatology&rft.au=Hiranuma,%20Susumu&rft.date=2007-12&rft.volume=22&rft.issue=12&rft.spage=2167&rft.epage=2172&rft.pages=2167-2172&rft.issn=0815-9319&rft.eissn=1440-1746&rft_id=info:doi/10.1111/j.1440-1746.2006.04779.x&rft_dat=%3Cproquest_cross%3E68544363%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68544363&rft_id=info:pmid/18031376&rfr_iscdi=true